NCT07222605 · ENROLLING BY INVITATION
Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device
This pilot study tests a wearable head device called MemorEM in people with neurological diseases including Alzheimer's, Parkinson's, and frontotemporal dementia. Researchers are not measuring treatment effectiveness here — they are gathering feedback on comfort, ease of use, and compliance to guide future device design. It is listed as Phase NA, meaning this is a user-experience feedback study, not a clinical efficacy trial. Details beyond that are limited.
You may qualify if
- Patient diagnosed with a neurological disease involving aggregated proteins such as Alzheimer's and its variants, Parkinson's, Frontotemporal dementia, Amyotrophic lateral sclerosis, Tauopathies, and other related neurological diseases.
- Presence of a caregiver(s) responsible for ensuring treatment compliance and potentially with authority to make medical decisions for the patient if the patient is not competent to make those decisions.
- A statement from each patient's physician that indicates the patient has the ability to understand and consent on their own AND they have the willingness to sign CareONE's patient consent.
You're excluded if
- Patient has Seizures, Epilepsy, uncontrolled Depression, uncontrolled Bipolar disorder, psychotic disorders, alcoholism or drug addiction
- Presence of metal implants in the head, except for metal dental implants
- Patient has hypertension that is unresponsive to anti-hypertensive medications
- Patient has implanted medication pumps unless cleared by physician
- Patient has significant heart disease, as determined by a physician
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-02-05